Cargando…
Combining endocannabinoids with retigabine for enhanced M-channel effect and improved K(V)7 subtype selectivity
Retigabine is unique among anticonvulsant drugs by targeting the neuronal M-channel, which is composed of K(V)7.2/K(V)7.3 and contributes to the negative neuronal resting membrane potential. Unfortunately, retigabine causes adverse effects, which limits its clinical use. Adverse effects may be reduc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rockefeller University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398146/ https://www.ncbi.nlm.nih.gov/pubmed/32365171 http://dx.doi.org/10.1085/jgp.202012576 |